Table 2 Linear/logistic regressions between WHO guidelines at baseline with MVPA and meeting WHO guidelines at follow-up

n

ß

B

95% CI

Adj R²

P

Whole Sample ^a

1886

8.3

.13

5.4, 11.1

.24

< 0.001

 Males ^b

916

9.7

.16

5.3, 14.1

.20

< 0.001

 Females ^b

970

7.4

.12

3.5, 11.3

.24

< 0.001

 Pre/Early Pubertal Males ^c

399

10.8

.17

3.4, 18.2

.21

0.004

 Pubertal Males ^c

473

6.9

.12

1.1, 12.8

.16

0.020

 Pre/Early Pubertal Females ^c

419

14.6

.24

9.1, 20.1

.29

< 0.001

 Pubertal Females ^c

507

−.26

.00

−6.1, 5.6

.21

0.931

n

95% CI

R²

P

Whole Sample ^a

1886

1.5, 3.1

.21

< 0.001

 Males ^b

916

1.5, 4.3

.19

< 0.001

 Females ^b

970

1.1, 3.4

.20

0.027

 Pre/Early Pubertal Males ^c

399

1.6, 8.9

.24

0.02

 Pubertal Males ^c

473

.87, 3.5

.17

0.118

 Pre/Early Pubertal Females ^c

419

2.2, 11.7

.27

< 0.001

 Pubertal Females ^c

507

.23, 1.6

.20

0.327